ARTICLESHow CDMO Manufacturing Supports Innovation in Small Molecule & Biologic Drugs
How strategic CDMO partnerships enable faster execution, scalable development, and smarter decision-making in modern drug innovation
See moreIndustry News
Check out the latest trends in the contract manufacturing industry
28 articles
ARTICLES
ARTICLESHow Biopharmaceutical CDMOs Optimize Cell Line Development & Process Yields
Beyond Capacity: How Smarter Science is Redefining Biologics Manufacturing
See more
ARTICLESHow Fill Finish CDMOs Validate and Qualify Sterile Lines
The Backbone of Patient Safety: Navigating Aseptic Process Simulation and Equipment Qualification in Sterile Manufacturing.
See more
ARTICLESAdvanced Bioconjugation Techniques in ADC CDMO Production
From Random to Controlled: Navigating the Technical Evolution and Manufacturing Hurdles of Antibody-Drug Conjugates.
See moreARTICLESKey Capabilities to Look for in a Contract Manufacturing Organization
What truly matters when selecting a Contract Manufacturing Organization for clinical and commercial success
See moreARTICLESWhy Regulatory Experience Is Critical When Choosing a Veterinary CDMO
Regulatory expertise can be the difference between a smooth veterinary drug approval and costly delays.
See moreARTICLESPharma Licensing (In-licensing & Out-licensing): What It Is and Why It Matters
How In-licensing and Out-licensing Drive Growth, Collaboration, and Speed in Drug Development
See moreARTICLESInterview with Javier Ruiz Sanz, Associate Director Business Development at Pharmaron
Pharmaron is a leading life sciences service provider, offering a wide range of research, development, and manufacturing capabilities across the entire drug discovery, preclinical, clinical development, and commercialization process.
See more
ARTICLESInterview with Bartlomiej Czubek, Director of Business Development at Mabion
Mabion is a CDMO company specializing in the advanced manufacturing and development of biological products, with extensive experience in monoclonal antibodies. Founded in 2007 and headquartered in the EU, in Poland.
See more